Guyer D R, Tiedeman J, Yannuzzi L A, Slakter J S, Parke D, Kelley J, Tang R A, Marmor M, Abrams G, Miller J W
Retinal Research Laboratory, Manhattan Eye, Ear, and Throat Hospital, New York, NY 10021.
Arch Ophthalmol. 1993 Mar;111(3):350-6. doi: 10.1001/archopht.1993.01090030068041.
Interferon alfa is used to treat various systemic disorders and recently has been suggested as a possible treatment for choroidal neovascularization. We report 10 cases of retinal ischemia associated with the use of interferon alfa for various illnesses. The retinal findings include cotton-wool spot formation, capillary nonperfusion, arteriolar occlusion, and hemorrhage. The retinal complications may sometimes be reversible when treatment is stopped. Our findings emphasize the need to have patients who are receiving interferon alfa therapy monitored for these retinal complications, which may rarely be associated with permanent loss of vision secondary to closure of retinal capillaries.
干扰素α用于治疗各种全身性疾病,最近有人提出它可能是治疗脉络膜新生血管的一种方法。我们报告了10例因使用干扰素α治疗各种疾病而导致视网膜缺血的病例。视网膜表现包括棉絮斑形成、毛细血管无灌注、小动脉阻塞和出血。当停止治疗时,视网膜并发症有时可能是可逆的。我们的研究结果强调,需要对接受干扰素α治疗的患者进行监测,以发现这些视网膜并发症,这些并发症很少会导致因视网膜毛细血管闭合而导致永久性视力丧失。